Carregant...
Perforation of the colon by invading recurrent gastrointestinal stromal tumors during sunitinib treatment
The molecular targets of sunitinib are receptor tyrosine kinases (RTKs), and this drug has also been known to exert blocking effects on the activation of KIT, which is similar to the mechanism of action of imatinib. Moreover, sunitinib has an additional anti-angiogenic effect through its inhibition...
Guardat en:
| Autors principals: | , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
The WJG Press and Baishideng
2008
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2760196/ https://ncbi.nlm.nih.gov/pubmed/18932293 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.14.6096 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|